PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
92 hedge funds and large institutions have $282M invested in Paratek Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% more funds holding
Funds holding: 86 → 92 (+6)
74% less call options, than puts
Call options by funds: $388K | Put options by funds: $1.47M
Holders
92
Holding in Top 10
5
Calls
$388K
Puts
$1.47M
Top Buyers
| 1 | +$5.99M | |
| 2 | +$3.85M | |
| 3 | +$2.42M | |
| 4 |
NC
Nexthera Capital
New York
|
+$1.54M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.32M |
Top Sellers
| 1 | -$4.27M | |
| 2 | -$2.39M | |
| 3 | -$1.33M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$781K |